These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 29917326)

  • 61. Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases.
    Stremitzer S; Vermeulen P; Graver S; Kockx M; Dirix L; Yang D; Zhang W; Stift J; Wrba F; Gruenberger T; Lenz HJ; Scherer SJ
    Br J Cancer; 2020 May; 122(10):1518-1524. PubMed ID: 32205863
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Histopathological growth patterns of neuroendocrine tumor liver metastases.
    Meyer Y; Bohlok A; Olthof P; Donckier V; Doukas M; Lucidi V; Vermeulen P; Grünhagen D; Verhoef C
    Clin Exp Metastasis; 2023 Jun; 40(3):227-234. PubMed ID: 37183203
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical and cytogenetic analyses in uveal melanoma.
    Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term survival in a patient with uveal melanoma and liver metastasis.
    Duh EJ; Schachat AP; Albert DM; Patel SM
    Arch Ophthalmol; 2004 Feb; 122(2):285-7. PubMed ID: 14769612
    [No Abstract]   [Full Text] [Related]  

  • 65. Characterization of computed tomography scan abnormalities in patients with biopsy-proven hepatic metastases from uveal melanoma.
    Patel M; Winston CB; Marr BP; Carvajal RD; Schwartz GK; Wolchok J; Busam K; Abramson DH
    Arch Ophthalmol; 2011 Dec; 129(12):1576-82. PubMed ID: 22159677
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival.
    Vogl T; Eichler K; Zangos S; Herzog C; Hammerstingl R; Balzer J; Gholami A
    J Cancer Res Clin Oncol; 2007 Mar; 133(3):177-84. PubMed ID: 17021903
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
    Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
    Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
    [TBL] [Abstract][Full Text] [Related]  

  • 68. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
    Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
    JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nucleolar size in choroidal and ciliary body melanomas and corresponding hepatic metastases.
    Al-Jamal RT; Toivonen P; Kivelä T
    Acta Ophthalmol; 2010 Jun; 88(4):458-62. PubMed ID: 19549104
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
    Petrovic A; Bergin C; Schalenbourg A; Goitein G; Zografos L
    Ophthalmology; 2014 Apr; 121(4):898-904. PubMed ID: 24405742
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma.
    Kim IK; Lane AM; Gragoudas ES
    Arch Ophthalmol; 2010 Jul; 128(7):871-5. PubMed ID: 20625048
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Uveal melanoma prognostication: from lesion size and cell type to molecular class.
    Gill HS; Char DH
    Can J Ophthalmol; 2012 Jun; 47(3):246-53. PubMed ID: 22687301
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
    van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Survival of patients with metastases from uveal melanoma.
    Gragoudas ES; Egan KM; Seddon JM; Glynn RJ; Walsh SM; Finn SM; Munzenrider JE; Spar MD
    Ophthalmology; 1991 Mar; 98(3):383-9; discussion 390. PubMed ID: 2023760
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A retrospective analysis of 141 patients with liver metastases from uveal melanoma: a two-cohort study comparing transarterial chemoembolization with CPT-11 charged microbeads and historical treatments.
    Valpione S; Aliberti C; Parrozzani R; Bazzi M; Pigozzo J; Midena E; Pilati P; Campana LG; Chiarion-Sileni V
    Melanoma Res; 2015 Apr; 25(2):164-8. PubMed ID: 25521594
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The biological and prognostic significance of angiotropism in uveal melanoma.
    Barnhill RL; Ye M; Batistella A; Stern MH; Roman-Roman S; Dendale R; Lantz O; Piperno-Neumann S; Desjardins L; Cassoux N; Lugassy C
    Lab Invest; 2017 Jun; 97(6):746-759. PubMed ID: 28240745
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical Characteristics of UM and Association of Metastasis of Uveal Melanoma with Congenital Oculocutaneous Melanosis in Asian Patients: Analysis of 1151 Consecutive Eyes.
    Zhou N; Zhang R; Liu Y; Wei W
    Ophthalmol Retina; 2021 Nov; 5(11):1164-1172. PubMed ID: 33444806
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Microcirculation and tumor-infiltrating macrophages in choroidal and ciliary body melanoma and corresponding metastases.
    Toivonen P; Mäkitie T; Kujala E; Kivelä T
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):1-6. PubMed ID: 14691146
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Value of histopathological growth pattern in predicting 3-year progression free survival after operation in patients with liver metastasis of colorectal cancer].
    Zhang YL; He HJ; Cheng J; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2021 Jan; 50(1):26-31. PubMed ID: 33396983
    [No Abstract]   [Full Text] [Related]  

  • 80. sIL-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma.
    Barak V; Kalickman I; Pe'er J
    Anticancer Res; 2022 Mar; 42(3):1447-1453. PubMed ID: 35220238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.